Company intelligence
IRB Barcelona
International biomedical #research center devoted to curing #cancer and other diseases linked to #aging. CERCA-BIST.
About IRB Barcelona
At IRB Barcelona, we believe that understanding life at its most fundamental level is the fastest route to curing disease. We are a leading international biomedical research institute where more than 500 scientists from 41 countries tackle three of medicine's greatest frontiers: Cancer Science, Aging & Metabolism, and the Mechanisms of Disease. Every experiment, every discovery, every late night in the lab has one ultimate goal: improving patients' lives. Our science doesn't stop at the bench. Six spin-off companies (among them Inbiomotion, Nuage, Nostrum Biodiscovery, and Ona Therapeutics) are already bringing our findings into the clinic and the market. Founded in 2005, based at Barcelona Science Park, and recognised four consecutive times with Spain's Severo Ochoa Centre of Excellence distinction, IRB Barcelona is where rigorous science meets real-world ambition. We are always looking for bold minds to join us. Come and work on questions that matter.
Verified activity
Signals from IRB Barcelona
5 published signals
People
IRB Barcelona is hiring an Academic Officer to join the People and Academic Affairs Department and report to the Academic Coordinator.
Reported by IRB Barcelona
Presence & Recognition
IRB Barcelona announced the winners of the Maths4Life 2026 programme on presenting their projects today
Reported by IRB Barcelona
People
IRB Barcelona is hiring a Postdoctoral Fellow for the Cell Signaling Research Group led by Dr. Francesc Posas and Dr. Laia de Nadal.
Reported by IRB Barcelona
Research & Knowledge
IRB Barcelona congratulated doctoral student Ines Maria Garcia Perez on the successful defense of her doctoral thesis in the Targeted Protein Degradation lab.
Reported by IRB Barcelona
Research & Knowledge
IRB Barcelona published an article in Diario ABC discussing the scientific perspective and importance of studying the tolerance, toxicity, quality, and balance benefits of peptides like BPC-157 and TB-500.
Reported by IRB Barcelona